HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single bolus injection of bilirubin improves the clinical outcome in a mouse model of endotoxemia.

Abstract
Increasing serum levels of biliverdin and bilirubin was shown to be beneficial in settings of inflammation. Bilirubin was shown to be protective in LPS-induced lung injury in rats; however, the exact mechanism remains elusive. Here, we investigated whether a single bolus injection of bilirubin would exert anti-inflammatory effects in a mouse model of endotoxemia. Mice were challenged with sublethal doses (2 mg/kg body weight) of LPS, and the effects of intravenously administered bilirubin (40 mg/kg body weight) were assessed. In contrast to control animals, bilirubin-treated animals fully recovered from endotoxin shock within 24 h. Bilirubin treatment improved the clinical score significantly at all time points assessed, attenuated weight loss, and improved LPS-induced anorexia. Furthermore, bilirubin treatment inhibited LPS-induced leukocyte-endothelial interactions and leukocyte accumulation in various tissues. Expression of inflammatory genes, including endothelial adhesion molecules, but also IL-1beta and TNF-alpha, was significantly reduced in bilirubin-treated animals. Moreover, bilirubin inhibited LPS-induced expression of inflammatory genes in isolated cultured aortic endothelial cells and in bone marrow-derived macrophages. These data show that single-dose administration of bilirubin attenuates tissue injury induced by endotoxin, and that bilirubin, in addition to its antioxidant effects, also exerts potent anti-inflammatory activity.
AuthorsAlexandra Kadl, Jens Pontiller, Markus Exner, Norbert Leitinger
JournalShock (Augusta, Ga.) (Shock) Vol. 28 Issue 5 Pg. 582-8 (Nov 2007) ISSN: 1073-2322 [Print] United States
PMID17577133 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Antioxidants
  • Cell Adhesion Molecules
  • Inflammation Mediators
  • Interleukin-1beta
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Biliverdine
  • Bilirubin
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Antioxidants (pharmacology)
  • Bilirubin (blood, pharmacology)
  • Biliverdine (blood)
  • Cell Adhesion Molecules (biosynthesis)
  • Cell Communication (drug effects)
  • Cells, Cultured
  • Disease Models, Animal
  • Endothelial Cells (metabolism, pathology)
  • Endotoxemia (chemically induced, drug therapy, metabolism, pathology)
  • Gene Expression Regulation (drug effects)
  • Inflammation Mediators (metabolism)
  • Interleukin-1beta (biosynthesis)
  • Leukocytes (metabolism, pathology)
  • Lipopolysaccharides (toxicity)
  • Lung (metabolism, pathology)
  • Lung Injury
  • Macrophages (metabolism, pathology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Rats
  • Time Factors
  • Tumor Necrosis Factor-alpha (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: